{"name":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","slug":"pfizer-s-upjohn-has-merged-with-mylan-to-form-viatris-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":19,"colorKey":"immunology","drugs":[{"name":"Detrol LA","genericName":"Detrol LA","slug":"detrol-la","indication":"Overactive bladder with symptoms of urge incontinence, urgency, and frequency","status":"marketed"},{"name":"Sequence 4 - Treatment A: Controlled Release Pregabalin","genericName":"Sequence 4 - Treatment A: Controlled Release Pregabalin","slug":"sequence-4-treatment-a-controlled-release-pregabalin","indication":"Other","status":"phase_1"},{"name":"Sequence 4 - Treatment B: Controlled Release Pregabalin","genericName":"Sequence 4 - Treatment B: Controlled Release Pregabalin","slug":"sequence-4-treatment-b-controlled-release-pregabalin","indication":"Other","status":"phase_1"},{"name":"Atorvastatin and Omega-3 fatty acids","genericName":"Atorvastatin and Omega-3 fatty acids","slug":"atorvastatin-and-omega-3-fatty-acids","indication":"Other","status":"marketed"},{"name":"B16 Fasted","genericName":"B16 Fasted","slug":"b16-fasted","indication":"Other","status":"phase_1"},{"name":"B16 Fed","genericName":"B16 Fed","slug":"b16-fed","indication":"Other","status":"phase_1"},{"name":"Blood samples for the analysis of sildenafil in plasma","genericName":"Blood samples for the analysis of sildenafil in plasma","slug":"blood-samples-for-the-analysis-of-sildenafil-in-plasma","indication":"Other","status":"marketed"},{"name":"Epamin","genericName":"Epamin","slug":"epamin","indication":"Other","status":"phase_1"},{"name":"Formulation D ODT tablet 50 mg","genericName":"Formulation D ODT tablet 50 mg","slug":"formulation-d-odt-tablet-50-mg","indication":"Other","status":"phase_1"},{"name":"Selara","genericName":"Selara","slug":"selara","indication":"Other","status":"phase_2"},{"name":"Sequence 2 - Treatment D: Controlled Release Pregabalin","genericName":"Sequence 2 - Treatment D: Controlled Release Pregabalin","slug":"sequence-2-treatment-d-controlled-release-pregabalin","indication":"Other","status":"phase_1"},{"name":"Xalacom","genericName":"Xalacom","slug":"xalacom","indication":"Other","status":"marketed"},{"name":"celecoxib test formulation C1","genericName":"celecoxib test formulation C1","slug":"celecoxib-test-formulation-c1","indication":"Other","status":"phase_1"},{"name":"iv sildenafil","genericName":"iv sildenafil","slug":"iv-sildenafil","indication":"Erectile dysfunction","status":"phase_3"},{"name":"latanoprost 0.005% ophthalmic solution","genericName":"latanoprost 0.005% ophthalmic solution","slug":"latanoprost-0-005-ophthalmic-solution","indication":"Other","status":"marketed"},{"name":"pregabalin and celecoxib","genericName":"pregabalin and celecoxib","slug":"pregabalin-and-celecoxib","indication":"Other","status":"marketed"},{"name":"sildanefil","genericName":"sildanefil","slug":"sildanefil","indication":"Other","status":"discontinued"},{"name":"tolterodine SR, overactive bladder","genericName":"tolterodine SR, overactive bladder","slug":"tolterodine-sr-overactive-bladder","indication":"Other","status":"marketed"},{"name":"ziprazidone","genericName":"ziprazidone","slug":"ziprazidone","indication":"Other","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":10,"colorKey":"neuroscience","drugs":[{"name":"Pregabalin Dose Level 2","genericName":"Pregabalin Dose Level 2","slug":"pregabalin-dose-level-2","indication":"Neuropathic pain (diabetic peripheral neuropathy, postherpetic neuralgia, spinal cord injury)","status":"phase_3"},{"name":"Pregabalin add-on therapy","genericName":"Pregabalin add-on therapy","slug":"pregabalin-add-on-therapy","indication":"Neuropathic pain (add-on therapy)","status":"phase_3"},{"name":"Zoloft tablets","genericName":"Zoloft tablets","slug":"zoloft-tablets","indication":"Major depressive disorder","status":"marketed"},{"name":"placebo and pregabalin","genericName":"placebo and pregabalin","slug":"placebo-and-pregabalin","indication":"Neuropathic pain","status":"phase_3"},{"name":"Geodon (Ziprasidone)","genericName":"Geodon (Ziprasidone)","slug":"geodon-ziprasidone","indication":"Schizophrenia","status":"phase_3"},{"name":"Intramuscular ziprasidone mesylate","genericName":"Intramuscular ziprasidone mesylate","slug":"intramuscular-ziprasidone-mesylate","indication":"Acute agitation associated with schizophrenia or bipolar disorder","status":"phase_3"},{"name":"Lyrica (pregabalin)","genericName":"Lyrica (pregabalin)","slug":"lyrica-pregabalin","indication":"Neuropathic pain (diabetic peripheral neuropathy, postherpetic neuralgia, spinal cord injury)","status":"marketed"},{"name":"Oxybutynin ER","genericName":"Oxybutynin ER","slug":"oxybutynin-er","indication":"Overactive bladder with symptoms of urge incontinence, urgency, and frequency","status":"marketed"},{"name":"Placebo matched with pregabalin","genericName":"Placebo matched with pregabalin","slug":"placebo-matched-with-pregabalin","indication":"Neuropathic pain","status":"phase_3"},{"name":"Pregabalin Dose Level 1","genericName":"Pregabalin Dose Level 1","slug":"pregabalin-dose-level-1","indication":"Neuropathic pain (diabetic peripheral neuropathy, postherpetic neuralgia, spinal cord injury)","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":8,"colorKey":"oncology","drugs":[{"name":"Travoprost 004% sterile ophthalmic solution","genericName":"Travoprost 004% sterile ophthalmic solution","slug":"travoprost-004-sterile-ophthalmic-solution","indication":"Open-angle glaucoma","status":"marketed"},{"name":"fixed combination latanoprost-timolol","genericName":"fixed combination latanoprost-timolol","slug":"fixed-combination-latanoprost-timolol","indication":"Glaucoma, Ocular hypertension","status":"phase_3"},{"name":"Amlodipine/Atorvastatin","genericName":"Amlodipine/Atorvastatin","slug":"amlodipine-atorvastatin","indication":"Hypertension and dyslipidemia in patients requiring both agents","status":"marketed"},{"name":"Doxazosin mysylate GITS","genericName":"Doxazosin mysylate GITS","slug":"doxazosin-mysylate-gits","indication":"Benign prostatic hyperplasia with lower urinary tract symptoms","status":"marketed"},{"name":"Viagra (sildenafil citrate)","genericName":"Viagra (sildenafil citrate)","slug":"viagra-sildenafil-citrate","indication":"Erectile dysfunction","status":"marketed"},{"name":"Xalatan","genericName":"Xalatan","slug":"xalatan","indication":"Ocular hypertension","status":"marketed"},{"name":"iso- 5 - mononitrate","genericName":"iso- 5 - mononitrate","slug":"iso-5-mononitrate","indication":"Angina pectoris (prophylaxis and acute relief)","status":"marketed"},{"name":"unfixed Latanoprost and Timolol","genericName":"unfixed Latanoprost and Timolol","slug":"unfixed-latanoprost-and-timolol","indication":"Glaucoma","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"cardiovascular","drugs":[{"name":"Placebo and celecoxib","genericName":"Placebo and celecoxib","slug":"placebo-and-celecoxib","indication":"Rheumatoid arthritis","status":"marketed"},{"name":"Diclofenac + Omeprazole","genericName":"Diclofenac + Omeprazole","slug":"diclofenac-omeprazole","indication":"Rheumatoid arthritis with gastric protection","status":"marketed"},{"name":"Ibuprofen plus Omeprazole","genericName":"Ibuprofen plus Omeprazole","slug":"ibuprofen-plus-omeprazole","indication":"Osteoarthritis pain with gastric protection","status":"marketed"},{"name":"Non-selective NSAIDS","genericName":"Non-selective NSAIDS","slug":"non-selective-nsaids","indication":"Mild to moderate pain","status":"marketed"}]}],"pipeline":[{"name":"Travoprost 004% sterile ophthalmic solution","genericName":"Travoprost 004% sterile ophthalmic solution","slug":"travoprost-004-sterile-ophthalmic-solution","phase":"marketed","mechanism":"Travoprost is a prostaglandin F analog that binds to prostaglandin F (FP) receptors in the eye to increase uveoscleral outflow of aqueous humor, thereby lowering intraocular pressure.","indications":["Open-angle glaucoma","Ocular hypertension"],"catalyst":""},{"name":"fixed combination latanoprost-timolol","genericName":"fixed combination latanoprost-timolol","slug":"fixed-combination-latanoprost-timolol","phase":"phase_3","mechanism":"Latanoprost-timolol is a fixed combination of a prostaglandin analog and a beta-blocker that works by reducing intraocular pressure in the eye.","indications":["Glaucoma, Ocular hypertension"],"catalyst":""},{"name":"Amlodipine/Atorvastatin","genericName":"Amlodipine/Atorvastatin","slug":"amlodipine-atorvastatin","phase":"marketed","mechanism":"This combination drug reduces blood pressure by blocking calcium channels in blood vessels and lowers cholesterol by inhibiting HMG-CoA reductase.","indications":["Hypertension and dyslipidemia in patients requiring both agents","Reduction of cardiovascular risk in patients with coronary artery disease or multiple cardiovascular risk factors"],"catalyst":""},{"name":"Detrol LA","genericName":"Detrol LA","slug":"detrol-la","phase":"marketed","mechanism":"Detrol LA is a muscarinic receptor antagonist that blocks acetylcholine signaling in the bladder to reduce involuntary muscle contractions and urinary urgency.","indications":["Overactive bladder with symptoms of urge incontinence, urgency, and frequency"],"catalyst":""},{"name":"Placebo and celecoxib","genericName":"Placebo and celecoxib","slug":"placebo-and-celecoxib","phase":"marketed","mechanism":"Celecoxib selectively inhibits cyclooxygenase-2 (COX-2), reducing the production of prostaglandins that mediate inflammation and pain.","indications":["Rheumatoid arthritis","Osteoarthritis","Acute pain","Primary dysmenorrhea","Familial adenomatous polyposis (FAP)"],"catalyst":""},{"name":"Pregabalin Dose Level 2","genericName":"Pregabalin Dose Level 2","slug":"pregabalin-dose-level-2","phase":"phase_3","mechanism":"Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters.","indications":["Neuropathic pain (diabetic peripheral neuropathy, postherpetic neuralgia, spinal cord injury)","Partial-onset seizures (adjunctive therapy)","Generalized anxiety disorder","Fibromyalgia"],"catalyst":""},{"name":"Pregabalin add-on therapy","genericName":"Pregabalin add-on therapy","slug":"pregabalin-add-on-therapy","phase":"phase_3","mechanism":"Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters.","indications":["Neuropathic pain (add-on therapy)","Partial-onset seizures (add-on therapy)","Generalized anxiety disorder (add-on therapy)"],"catalyst":""},{"name":"Sequence 4 - Treatment A: Controlled Release Pregabalin","genericName":"Sequence 4 - Treatment A: Controlled Release Pregabalin","slug":"sequence-4-treatment-a-controlled-release-pregabalin","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Sequence 4 - Treatment B: Controlled Release Pregabalin","genericName":"Sequence 4 - Treatment B: Controlled Release Pregabalin","slug":"sequence-4-treatment-b-controlled-release-pregabalin","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Zoloft tablets","genericName":"Zoloft tablets","slug":"zoloft-tablets","phase":"marketed","mechanism":"Zoloft selectively inhibits the reuptake of serotonin at the neuronal synapse, increasing serotonin availability in the brain.","indications":["Major depressive disorder","Obsessive-compulsive disorder","Panic disorder","Posttraumatic stress disorder","Social anxiety disorder"],"catalyst":""},{"name":"placebo and pregabalin","genericName":"placebo and pregabalin","slug":"placebo-and-pregabalin","phase":"phase_3","mechanism":"Pregabalin is a structural analog of the neurotransmitter gamma-aminobutyric acid (GABA) and acts as a GABA receptor agonist.","indications":["Neuropathic pain","Fibromyalgia"],"catalyst":""},{"name":"Atorvastatin and Omega-3 fatty acids","genericName":"Atorvastatin and Omega-3 fatty acids","slug":"atorvastatin-and-omega-3-fatty-acids","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"B16 Fasted","genericName":"B16 Fasted","slug":"b16-fasted","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"B16 Fed","genericName":"B16 Fed","slug":"b16-fed","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Blood samples for the analysis of sildenafil in plasma","genericName":"Blood samples for the analysis of sildenafil in plasma","slug":"blood-samples-for-the-analysis-of-sildenafil-in-plasma","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Diclofenac + Omeprazole","genericName":"Diclofenac + Omeprazole","slug":"diclofenac-omeprazole","phase":"marketed","mechanism":"Diclofenac inhibits prostaglandin synthesis to reduce inflammation and pain, while omeprazole suppresses gastric acid production to protect against NSAID-induced ulcers.","indications":["Rheumatoid arthritis with gastric protection","Osteoarthritis with gastric protection","Ankylosing spondylitis with gastric protection","Acute pain conditions requiring NSAID therapy with gastroprotection"],"catalyst":""},{"name":"Doxazosin mysylate GITS","genericName":"Doxazosin mysylate GITS","slug":"doxazosin-mysylate-gits","phase":"marketed","mechanism":"Doxazosin is an alpha-1 adrenergic receptor antagonist that relaxes smooth muscle in the prostate and bladder neck to improve urinary flow, and also dilates blood vessels to lower blood pressure.","indications":["Benign prostatic hyperplasia with lower urinary tract symptoms","Hypertension"],"catalyst":""},{"name":"Epamin","genericName":"Epamin","slug":"epamin","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Formulation D ODT tablet 50 mg","genericName":"Formulation D ODT tablet 50 mg","slug":"formulation-d-odt-tablet-50-mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Geodon (Ziprasidone)","genericName":"Geodon (Ziprasidone)","slug":"geodon-ziprasidone","phase":"phase_3","mechanism":"Ziprasidone is an atypical antipsychotic that blocks dopamine D2 and serotonin 5-HT2A receptors in the brain.","indications":["Schizophrenia","Acute agitation in patients with schizophrenia","Bipolar I disorder (acute manic or mixed episodes)"],"catalyst":""},{"name":"Ibuprofen plus Omeprazole","genericName":"Ibuprofen plus Omeprazole","slug":"ibuprofen-plus-omeprazole","phase":"marketed","mechanism":"Ibuprofen reduces inflammation and pain by inhibiting cyclooxygenase enzymes, while omeprazole protects the stomach by suppressing gastric acid production.","indications":["Osteoarthritis pain with gastric protection","Rheumatoid arthritis pain with gastric protection","Chronic pain conditions requiring NSAID therapy with reduced GI risk"],"catalyst":""},{"name":"Intramuscular ziprasidone mesylate","genericName":"Intramuscular ziprasidone mesylate","slug":"intramuscular-ziprasidone-mesylate","phase":"phase_3","mechanism":"Ziprasidone is an atypical antipsychotic that blocks dopamine D2 and serotonin 5-HT2A receptors in the brain.","indications":["Acute agitation associated with schizophrenia or bipolar disorder","Schizophrenia (maintenance and acute treatment)","Bipolar disorder (acute mania and maintenance)"],"catalyst":""},{"name":"Lyrica (pregabalin)","genericName":"Lyrica (pregabalin)","slug":"lyrica-pregabalin","phase":"marketed","mechanism":"Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters.","indications":["Neuropathic pain (diabetic peripheral neuropathy, postherpetic neuralgia, spinal cord injury)","Partial-onset seizures (adjunctive therapy)","Fibromyalgia","Generalized anxiety disorder"],"catalyst":""},{"name":"Non-selective NSAIDS","genericName":"Non-selective NSAIDS","slug":"non-selective-nsaids","phase":"marketed","mechanism":"Non-selective NSAIDs inhibit both COX-1 and COX-2 enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation, pain, and fever.","indications":["Mild to moderate pain","Rheumatoid arthritis","Osteoarthritis","Fever","Dysmenorrhea"],"catalyst":""},{"name":"Oxybutynin ER","genericName":"Oxybutynin ER","slug":"oxybutynin-er","phase":"marketed","mechanism":"Oxybutynin is an anticholinergic agent that blocks muscarinic acetylcholine receptors in the bladder smooth muscle, reducing involuntary contractions and increasing bladder capacity.","indications":["Overactive bladder with symptoms of urge incontinence, urgency, and frequency","Neurogenic detrusor overactivity in patients with spinal cord injury or other neurological conditions"],"catalyst":""},{"name":"Placebo matched with pregabalin","genericName":"Placebo matched with pregabalin","slug":"placebo-matched-with-pregabalin","phase":"phase_3","mechanism":"Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters.","indications":["Neuropathic pain","Partial-onset seizures","Generalized anxiety disorder","Postherpetic neuralgia"],"catalyst":""},{"name":"Pregabalin Dose Level 1","genericName":"Pregabalin Dose Level 1","slug":"pregabalin-dose-level-1","phase":"phase_3","mechanism":"Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters.","indications":["Neuropathic pain (diabetic peripheral neuropathy, postherpetic neuralgia, spinal cord injury)","Partial-onset seizures (adjunctive therapy)","Generalized anxiety disorder","Fibromyalgia"],"catalyst":""},{"name":"Selara","genericName":"Selara","slug":"selara","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Sequence 2 - Treatment D: Controlled Release Pregabalin","genericName":"Sequence 2 - Treatment D: Controlled Release Pregabalin","slug":"sequence-2-treatment-d-controlled-release-pregabalin","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Viagra (sildenafil citrate)","genericName":"Viagra (sildenafil citrate)","slug":"viagra-sildenafil-citrate","phase":"marketed","mechanism":"Sildenafil inhibits phosphodiesterase type 5 (PDE5), allowing cyclic GMP to accumulate and promote smooth muscle relaxation in the corpus cavernosum, increasing blood flow to the penis.","indications":["Erectile dysfunction","Pulmonary arterial hypertension","Benign prostatic hyperplasia symptoms"],"catalyst":""},{"name":"Xalacom","genericName":"Xalacom","slug":"xalacom","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Xalatan","genericName":"Xalatan","slug":"xalatan","phase":"marketed","mechanism":"Prostaglandin E2 receptor EP1 subtype, Prostaglandin E2 receptor EP3 subtype, Prostaglandin F2-alpha receptor","indications":["Ocular hypertension","Open-angle glaucoma"],"catalyst":""},{"name":"celecoxib test formulation C1","genericName":"celecoxib test formulation C1","slug":"celecoxib-test-formulation-c1","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"iso- 5 - mononitrate","genericName":"iso- 5 - mononitrate","slug":"iso-5-mononitrate","phase":"marketed","mechanism":"Isosorbide 5-mononitrate is a nitrate vasodilator that releases nitric oxide to relax vascular smooth muscle and improve blood flow.","indications":["Angina pectoris (prophylaxis and acute relief)","Coronary artery disease"],"catalyst":""},{"name":"iv sildenafil","genericName":"iv sildenafil","slug":"iv-sildenafil","phase":"phase_3","mechanism":"Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor that works by increasing blood flow to the penis to treat erectile dysfunction.","indications":["Erectile dysfunction"],"catalyst":""},{"name":"latanoprost 0.005% ophthalmic solution","genericName":"latanoprost 0.005% ophthalmic solution","slug":"latanoprost-0-005-ophthalmic-solution","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"pregabalin and celecoxib","genericName":"pregabalin and celecoxib","slug":"pregabalin-and-celecoxib","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"sildanefil","genericName":"sildanefil","slug":"sildanefil","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"tolterodine SR, overactive bladder","genericName":"tolterodine SR, overactive bladder","slug":"tolterodine-sr-overactive-bladder","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"unfixed Latanoprost and Timolol","genericName":"unfixed Latanoprost and Timolol","slug":"unfixed-latanoprost-and-timolol","phase":"phase_3","mechanism":"Latanoprost is a prostaglandin analogue that reduces intraocular pressure by increasing uveoscleral outflow, while Timolol is a beta-adrenergic receptor blocker that reduces intraocular pressure by decreasing aqueous humor production.","indications":["Glaucoma","Ocular hypertension"],"catalyst":""},{"name":"ziprazidone","genericName":"ziprazidone","slug":"ziprazidone","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxQWmJKRm9tTnQxckptYmRmbWFqT0pNOXdUNENvZW1MOTBzT0JrVndiTk5qd1pQM01oSVE2ZjZJWFhlbE5iTXJnVFJMSWx6b01SSzRZZnJQdG11NDZ0TmVjTFNFVjBTUnBwNi1NQWlsMGZEbWpRbURrRWVYZ3dtdGM1Y3BOMA?oc=5","date":"2025-04-08","type":"pipeline","source":"Utah News Dispatch","summary":"Utah to receive millions through another opioid settlement - Utah News Dispatch","headline":"Utah to receive millions through another opioid settlement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9LRmJFUDVDQjdtRkRKem1VcDJrTkZSV1NCVTFvZGhTMm1pMUo1VUpiUDhOR0lHVk1NTk5OR3BEV2FGRGdQaG1RTkZkMkY2RnFvdVA0ZGlJNkEydjRsRXZ4Q1hRV3hyQVk0U3poUTl30gFyQVVfeXFMTmFIdjdaU1lta2ZIQXJJWWJ3RWh1MEdBcVNLR0x4WkpOeXpGcmNWQzNfcFktWmE1Z2FWdkF3XzRLanpta2dwTEJUaFkzVnZQajFucGJldEZDSlpfUTlnS3lZYTBqUjZsQlN6VXFMdlNtYWRB?oc=5","date":"2025-02-07","type":"pipeline","source":"koreabiomed.com","summary":"Viatris, Pfizer, Vantive cut jobs in Korea - koreabiomed.com","headline":"Viatris, Pfizer, Vantive cut jobs in Korea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPZ1UwZHpIb2lIcHk2M3FIeXJUXzdOWFFjMlc2ZmZpOHdROFJ5Ym5iUTUtcXA0WEJYZV9xenpFTnB2S0ZSVk1hdkdSQUtWVmtXTl9ZbTBqaUR1WTg1X2ZZSmZJU3FUVExhX2RqZXVWOVJzckNuT1pETW9EbkZTWF8xdlhZNlZTSWhaTU8xaFdHR0VCWEp5QmU0Z2NDdEVVZEc4?oc=5","date":"2023-10-02","type":"pipeline","source":"TribLIVE.com","summary":"Viatris to sell several business segments for almost $7 billion - TribLIVE.com","headline":"Viatris to sell several business segments for almost $7 billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQLU9RU05YXzdYRG0yWUxqMWtleWVXenp4MmRWM0ZETVc0Q0YxWm8zVkUwOU9Cc0xORkdoOTIzZHN0VFM1VTV1dXNrRmFiOGY4UmNUclVBd3RqbjdfQ2d0dWF3eXY2dU96eVhXNTFieDcwbXM4d0tpWTNBSy1GMjhXMHdGWmxsRFV5RWJpbWUxWTlPZw?oc=5","date":"2022-09-01","type":"patent","source":"DCAT Value Chain Insights","summary":"Company Moves: The Latest in the Global Generics Market - DCAT Value Chain Insights","headline":"Company Moves: The Latest in the Global Generics Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNdXRydDJjR19fM1JkZ19JbkZoT1pwSDBSa2NPdGJjOC05QnZqeENIbjZlTTJrRmV4VW15d2dtTUY5SzVKb0tzcjZWa2tEeU90SFZMQ3NTd09qUmw5MFhKMnRFbWtQekRhT3pyZ2NqMFR6ak5ETGxDSm9LMmk1MTliakNONEFCWXdmd0NYQ0J2aG9VSUIwdDY1clQ4bnpBb19uVEhSdWtVeXJGUnZLeXc?oc=5","date":"2021-05-03","type":"deal","source":"Fierce Pharma","summary":"With Mylan-Upjohn merger wrapped, Viatris chairman Coury collects $29M in 2020 pay - Fierce Pharma","headline":"With Mylan-Upjohn merger wrapped, Viatris chairman Coury collects $29M in 2020 pay","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxQME5hRWttenJsYlQ2QWZLRkpUNEJLMkp2dlhfN3g3ZDQxN083b0gzQ3JsUmhTUVFoNmgtS1FybFE0d2dNMWJXMS10RnJyS2ZIdVJyYkR6TFZIcGRYYVlHeVlHalF6UFgyT0JUR3lpRC1wT3ZwSFVXUU85Q1NkSmRSNEZ5cDdSZkZxRGNFSHlyeE1JV19QTHYzT2tuV0xKNzNzVnF3eEdiQjlYVGJwSlh2QXl5aFUtVFVJNWVjSUdidlBWWGQ5?oc=5","date":"2020-12-11","type":"pipeline","source":"Fierce Pharma","summary":"Pfizer-Mylan combo Viatris to slash up to 9,000 jobs, shutter manufacturing plants in global cost-cutting drive - Fierce Pharma","headline":"Pfizer-Mylan combo Viatris to slash up to 9,000 jobs, shutter manufacturing plants in global cost-cutting drive","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2020-11-18","type":"deal","source":"medicaldialogues.in","summary":"Pfizer Upjohn concludes merger with Mylan to create Viatris - medicaldialogues.in","headline":"Pfizer Upjohn concludes merger with Mylan to create Viatris","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxPYk9vNXFWNG5RVDFISVFwNEJKRWpicERtNDNRM0d3MnkzLU1qQkFPVFg1RDU5V3FRWlVKa1R5d1ZweWxtS1l2VG11MGtGR1c1ZzNvaEgzMElDcFhPLXNkeU5PRG1feUh1cklSYXM3NzVyQTZHWjNfaGN0RUNoQzVvckstQnhOdzVWU1RfdFlGMXh0bGY0QlBRTUhIaUJEWUpsbjFvelJlWXVBaTdvallOV0djWHhoTTJEWklISFFDVzl3N0hSQkkw?oc=5","date":"2020-11-16","type":"deal","source":"The Irish Times","summary":"Pfizer’s Upjohn spin-off completes merger with Mylan to form Viatris - The Irish Times","headline":"Pfizer’s Upjohn spin-off completes merger with Mylan to form Viatris","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxQcmd5NTdIQWZadFpieXh1OTNENS1QcTBfaVozSjk1STFWSjVuV2h4YnIwZDF3akFNakc4WDVpaVQzZC1LS0YxZldLTERXR0hWS0VyMzJMQkNzbENIUi05b2VPcjBXRGNJcGN3eVE4MWpWb3VUYUhRVEtNc2t0SW1BTDdHcVBlbE1RWmpadVo5anZpODBLNFVZTl9hNEI0MUJ1b3ZXMUpobVVRSTJ5R0owVHBBcDV3VGo4SGJ0ekNnS0pDYVlDYkU0QTFwdDR0T0xpcFExMXJQSldfVFBIemw2SlBUYS1DNm5kSEZ6TlZkaktCblR1QjZSX0pkZW5WMVNRamU0Znpwd0FpeC1zbi16WXNVdHBfOUNmazJldHpFYkRmRUdpSEItWnZLV0daUQ?oc=5","date":"2020-05-21","type":"pipeline","source":"Pfizer","summary":"Combining Upjohn and Mylan to Create a New Champion for Global Health - Pfizer","headline":"Combining Upjohn and Mylan to Create a New Champion for Global Health","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQNkE2QmQ4VU9FMjN6VEF1VFRfOUc1Q2h0TnhxRHdlRXFncFJNMVptM0N1eGxsT2xnbXYzUDZ3YzF5YnZOOXo0cVRGWEtFMnVEX25qdWxzSmJuczVFRlJJT3hITkVCbUJQVG1wd2JYQUc1bmpEaDZ2eDA3NnpSb0pQek4zcXNjcExvOEZ1QWszZTktS3o5VV9yWXd4MjMxNHBwSDQ3aVEtb3JWYWxNYTJodW5NSUZuZUtUN3drMklGSQ?oc=5","date":"2020-01-29","type":"pipeline","source":"Fierce Pharma","summary":"Pfizer is bulking up its Mylan-Upjohn spinoff but investors may not reap rewards: analysts - Fierce Pharma","headline":"Pfizer is bulking up its Mylan-Upjohn spinoff but investors may not reap rewards: analysts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQMENkaDZkZXRMY1k0ZUZYTk5pVW53a2phN0I0cEVpeHVCM1lpWkE0b0JGZXU0ZTVxWk40dDJsUTlxRlItdTBEbkt6UmxCajJHRDN1ZG9TclZOdXAxcWN6eWd4UGc5OXVNbjFBcEJGMDdkaTAtaTVmdzF6YnhyeFY1SU1hTVRMT0pZU0FTNjJ2MzExRGtvNlV5Tk5aSTB4NVg2Y1hOMDNkdkpDQm5xaGZfQ3ZNNFEyU3c?oc=5","date":"2020-01-09","type":"pipeline","source":"Fierce Pharma","summary":"Pfizer may look messy post-Upjohn spinoff, but better days could be ahead: analyst - Fierce Pharma","headline":"Pfizer may look messy post-Upjohn spinoff, but better days could be ahead: analyst","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOOGNGRXpaZmQ1MU1lalBfNk1lU1ZTR0VfRlAySWJHZFYtNjFqVmhHWHMxM1lJRGlfMnQ5WWpqd1ZMQWdTeVVWblI2Wk5feEpGLUo0THBFVVBMNjRsdGdGM3kyTUZLWF9PZm5BQlBuTHl4OHRFTWFCdHZWYjFrcWFKd2E2ak9Db2Mzd0pB?oc=5","date":"2019-11-13","type":"deal","source":"Pharmafile","summary":"Mylan and Upjohn merger will create a new entity: Viatris - Pharmafile","headline":"Mylan and Upjohn merger will create a new entity: Viatris","sentiment":"neutral"}],"patents":[],"drugCount":41,"phaseCounts":{"marketed":21,"phase_3":10,"phase_1":8,"phase_2":1,"discontinued":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}